Fisher & Paykel Healthcare Corporation Limited
FSPKF
$20.56
-$1.00-4.64%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 322.57M | 322.86M | 303.63M | 315.90M | 290.78M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 322.57M | 322.86M | 303.63M | 315.90M | 290.78M |
| Cost of Revenue | 119.37M | 119.47M | 110.01M | 114.45M | 110.82M |
| Gross Profit | 203.20M | 203.38M | 193.62M | 201.44M | 179.96M |
| SG&A Expenses | 84.61M | 84.68M | 77.74M | 80.88M | 79.63M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 237.78M | 238.00M | 220.90M | 229.82M | 224.11M |
| Operating Income | 84.78M | 84.86M | 82.73M | 86.08M | 66.67M |
| Income Before Tax | 84.10M | 84.18M | 84.27M | 87.67M | 63.10M |
| Income Tax Expenses | 20.98M | 21.00M | 20.69M | 21.53M | 16.26M |
| Earnings from Continuing Operations | 63.12M | 63.18M | 63.58M | 66.14M | 46.83M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 63.12M | 63.18M | 63.58M | 66.14M | 46.83M |
| EBIT | 84.78M | 84.86M | 82.73M | 86.08M | 66.67M |
| EBITDA | 103.69M | 103.78M | 98.43M | 102.41M | 84.28M |
| EPS Basic | 0.11 | 0.11 | 0.11 | 0.11 | 0.08 |
| Normalized Basic EPS | 0.09 | 0.09 | 0.09 | 0.09 | 0.07 |
| EPS Diluted | 0.11 | 0.11 | 0.11 | 0.11 | 0.08 |
| Normalized Diluted EPS | 0.09 | 0.09 | 0.09 | 0.09 | 0.07 |
| Average Basic Shares Outstanding | 586.59M | 586.59M | 586.13M | 586.13M | 584.95M |
| Average Diluted Shares Outstanding | 591.23M | 591.23M | 591.01M | 591.01M | 589.39M |
| Dividend Per Share | 0.06 | 0.06 | 0.07 | 0.07 | 0.06 |
| Payout Ratio | 54.40% | 54.40% | 42.92% | 42.92% | 47.04% |